Inogen, Inc · NASDAQ:INGN
Inogen — Shareholder Meeting (May 2023)
12 slides from Inogen's shareholder meeting presentation, May 11, 2023
Slide 1: Inogen, Inc. Stockholder Engagement May 2023
Inogen, Inc. Stockholder Engagement May 2023
Slide 2: Notice Regarding Forward-Looking Statements
Notice Regarding Forward-Looking Statements This presentation and the accompanying oral presentation (the “Presentation”) include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on current expectatio©ns, estimates and projections
Slide 3: Our Company and Purpose
Our Company and Purpose Inogen is a medical technology company. We are a global leader in portable oxygen therapy solutions for patients with chronic respiratory conditions. Our Purpose: Improving Lives through Respiratory Care Inogen ©2022 Inogen, Inc. All Rights Reserved. 3
Slide 4: Inogen Today
Inogen Today A global market leader with high quality, innovative, evidence-based chronic respiratory care solutions Locations in California, Ohio, Texas, Netherlands, Czech Republic1 Geographic Reach 60+ countries A Leader in Portable Oxygen Therapy Broad Reach Direct to Patient, Prescriber, HME, D
Slide 5: Revenue Overview
Revenue Overview Five-year Revenue CAGR of 8.6% through 2022 through four commercial channels [LINE_CHART] [CRICEL_CHART] 5 Year CAGR of 8.6% Revenue ($M) Revenue Breakdown (12 Months ended Dec 31, 2022) 1. 2020 was significantly impacted by the COVID-19 pandemic Inogen ©2022 Inogen, Inc. All Rights
Slide 6: Selected Financials
Selected Financials Solid Balance Sheet and Cash Balance with opportunities to improve gross margin as supply visibility improves As of December 31, 2022 Cash and cash equivalents $187.0M [BAR_CHART]Debt $0.0M Gross Margin Profile Inogen ©2022 Inogen, Inc. All Rights Reserved. 6
Slide 7: Board Members with Proven Track Record
Board Members with Proven Track Record Beth Mora Chairperson, Compliance Committee Chair Glenn Boehnlein Director, Audit Committee Chair Kevin King Director, Compensation Committee Chair Mary Katherine Ladone Director Tom West Director Heather Rider Director, Nominating and Governance Chair Nabil Sh
Slide 8: Compensation Philosophy
Compensation Philosophy Base Salary: Provide base pay that is fair and equitable and reflects current market conditions, roles and responsibilities, and other factors Bonuses: Support company strategy and incentivize achievement of key business objectives at all levels Reward & Recognition: Promote
Slide 9: Equity Program Incentivizes Retention and Revenue Growth
Equity Program Incentivizes Retention and Revenue Growth • Equity comprises 50-70% of total target annual compensation (excluding promotion and retention awards) for executives • Equity Portion of Total Target Annual Compensation • 50% of annual award is time-based, incentivizing retention, and • 50
Slide 10: Management Proposal: Approval of 2023 Equity Incentive Plan
Management Proposal: Approval of 2023 Equity Incentive Plan Repricing of awards is prohibited 1-year minimum vesting period (subject to certain limited exceptions) No dividends on unvested awards Outside director compensation limits No evergreen provision Share reserve includes 400,000 new shares, i
Slide 11: 2023 Annual Meeting of Stockholders
2023 Annual Meeting of Stockholders Proposal Recommendation Elect two Class III directors from the nominees As described in the proxy Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year ending December 31, 2023 Approve, on an
Slide 12: Inogen Improving lives through respiratory care
Inogen Improving lives through respiratory care